152 related articles for article (PubMed ID: 38449482)
1. Intestinal Perforation in a patient with peritoneal carcinomatosis from colon cancer treated with Regorafenib. Description of a case and review of the literature.
Bellia MA; Sofia C; Marino MA; Mazzeo C; Biondo SA; Cucinotta E; Fleres F
Radiol Case Rep; 2024 May; 19(5):2013-2019. PubMed ID: 38449482
[TBL] [Abstract][Full Text] [Related]
2. Regorafenib: a novel multitargeted tyrosine kinase inhibitor for colorectal cancer and gastrointestinal stromal tumors.
Crona DJ; Keisler MD; Walko CM
Ann Pharmacother; 2013 Dec; 47(12):1685-96. PubMed ID: 24259629
[TBL] [Abstract][Full Text] [Related]
3. Intestinal Perforation in a Patient with Colon Cancer during Treatment with Regorafenib: A Case Report and Review of the Literature.
Ouchi R; Okada K; Usui K; Kurata N; Suzuki S; Nagao M; Watanabe Y; Koyama K
Tohoku J Exp Med; 2021 Jul; 254(3):207-211. PubMed ID: 34321384
[TBL] [Abstract][Full Text] [Related]
4. Mixed response on regorafenib treatment for GIST (gastro-intestinal stromal tumor) according to
Van Weehaeghe D; Gheysens O; Vandecaveye V; Schöffski P; Van Laere K; Deroose CM
BMC Cancer; 2018 Mar; 18(1):253. PubMed ID: 29506493
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal perforation during regorafenib administration in a case with hepatic metastases of colon cancer.
Ogata K; Takamori H; Umezaki N; Yagi T; Ogawa K; Ozaki N; Hayashi H; Tanaka H; Ikuta Y; Doi K
J Chemother; 2017 Oct; 29(5):314-316. PubMed ID: 27438692
[TBL] [Abstract][Full Text] [Related]
6. [Corneal perforation with tyrosine kinase inhibitor chemotherapy: REGORAFENIB].
Lanfant L; Trone MC; Garcin T; Gauthier AS; Thuret G; Gain P
J Fr Ophtalmol; 2021 Apr; 44(4):544-548. PubMed ID: 33612324
[TBL] [Abstract][Full Text] [Related]
7. Radiological complete response with regorafenib for multiple lung metastases of ascending colon cancer: a case report.
Kikuchi K; Ogawa M; Sasaki A
J Med Case Rep; 2024 Feb; 18(1):45. PubMed ID: 38321556
[TBL] [Abstract][Full Text] [Related]
8. Severe and delayed-onset acneiform eruptions as an adverse reaction to regorafenib.
Otsuka H; Fukumoto T; Kiyota N; Takemori C; Jimbo H; Nishigori C
Dermatol Reports; 2022 Jun; 14(2):9303. PubMed ID: 35795830
[TBL] [Abstract][Full Text] [Related]
9. Pediatric sigmoid colonic perforation with Campylobacter enterocolitis: a case report and review of the literature.
Chu YY; Lin CY; Kuo TL; Mu SC; Lau BH; Chou YY
J Med Case Rep; 2022 Dec; 16(1):487. PubMed ID: 36581904
[TBL] [Abstract][Full Text] [Related]
10. Bowel perforation associated sunitinib therapy for recurred gastric gastrointestinal stromal tumor.
Kim HS; Kim SS; Park SG
Ann Surg Treat Res; 2014 Apr; 86(4):220-5. PubMed ID: 24783183
[TBL] [Abstract][Full Text] [Related]
11. Intestinal perforation in colorectal cancers treated with bevacizumab (Avastin).
Choi YI; Lee SH; Ahn BK; Baek SU; Park SJ; Kim YS; Shin SH
Cancer Res Treat; 2008 Mar; 40(1):33-5. PubMed ID: 19688063
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial.
Demetri GD; Reichardt P; Kang YK; Blay JY; Rutkowski P; Gelderblom H; Hohenberger P; Leahy M; von Mehren M; Joensuu H; Badalamenti G; Blackstein M; Le Cesne A; Schöffski P; Maki RG; Bauer S; Nguyen BB; Xu J; Nishida T; Chung J; Kappeler C; Kuss I; Laurent D; Casali PG;
Lancet; 2013 Jan; 381(9863):295-302. PubMed ID: 23177515
[TBL] [Abstract][Full Text] [Related]
13. Metastatic colorectal cancer responsive to regorafenib for 2 years: a case report.
Yoshino K; Manaka D; Kudo R; Kanai S; Mitsuoka E; Kanto S; Hamasu S; Konishi S; Nishitai R
J Med Case Rep; 2017 Aug; 11(1):227. PubMed ID: 28818109
[TBL] [Abstract][Full Text] [Related]
14. Ileum and colon perforation following peritoneal dialysis-related peritonitis and high-dose calcium polystyrene sulfonate.
Kao CC; Tsai YC; Chiang WC; Mao TL; Kao TW
J Formos Med Assoc; 2015 Oct; 114(10):1008-10. PubMed ID: 23602017
[TBL] [Abstract][Full Text] [Related]
15. Delayed Postoperative Intracerebral Hemorrhage Associated With Oral Multikinase Inhibitor Therapy for Cancer: A Case Report.
Patel VC; Krishnakumar A; Yang EH; Poklepovic AS; Broaddus WC
Cureus; 2024 Feb; 16(2):e55242. PubMed ID: 38558747
[TBL] [Abstract][Full Text] [Related]
16. Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study.
Van Cutsem E; Martinelli E; Cascinu S; Sobrero A; Banzi M; Seitz JF; Barone C; Ychou M; Peeters M; Brenner B; Hofheinz RD; Maiello E; André T; Spallanzani A; Garcia-Carbonero R; Arriaga YE; Verma U; Grothey A; Kappeler C; Miriyala A; Kalmus J; Falcone A; Zaniboni A
Oncologist; 2019 Feb; 24(2):185-192. PubMed ID: 30190299
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kinase inhibitor therapy.
Ben-Ami E; Barysauskas CM; von Mehren M; Heinrich MC; Corless CL; Butrynski JE; Morgan JA; Wagner AJ; Choy E; Yap JT; Van den Abbeele AD; Solomon SM; Fletcher JA; Demetri GD; George S
Ann Oncol; 2016 Sep; 27(9):1794-9. PubMed ID: 27371698
[TBL] [Abstract][Full Text] [Related]
18. Sigmoid Colon Tuberculosis Revealed by a Perforation and Peritonitis.
Ait Ali H; Zeriouh B; Jabi R; Bouziane M
Cureus; 2020 Dec; 12(12):e12272. PubMed ID: 33520488
[TBL] [Abstract][Full Text] [Related]
19. Regorafenib in Patients with Antiangiogenic-Naïve and Chemotherapy-Refractory Advanced Colorectal Cancer: Results from a Phase IIb Trial.
Riechelmann RP; Leite LS; Bariani GM; Glasberg J; Rivelli TG; da Fonseca LG; Nebuloni DR; Braghiroli MI; Queiroz MA; Isejima AM; Kappeler C; Kikuchi L; Hoff PM
Oncologist; 2019 Sep; 24(9):1180-1187. PubMed ID: 31175167
[TBL] [Abstract][Full Text] [Related]
20. Efficacy, Safety and Cost of Regorafenib in Patients with Metastatic Colorectal Cancer in French Clinical Practice.
Calcagno F; Lenoble S; Lakkis Z; Nguyen T; Limat S; Borg C; Jary M; Kim S; Nerich V
Clin Med Insights Oncol; 2016; 10():59-66. PubMed ID: 27398042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
